[Product].

Founder Securities: Participated in the swap facilitation business and obtained a no-objection reply from the China Securities Regulatory Commission

Founder Securities (601901) announced that the company recently obtained the China Securities Regulatory Commission's "Reply on Matters Related to Founder Securities Co., Ltd.'s Participation in Swap Facilitation" (hereinafter referred to as the "Reply"). According to the reply, the CSRC has no objection to the company's participation in the Swap Facility (SFISF).

Shanghai Pharmaceutical: Plans to acquire 10% of the equity of Shanghai Hutchison Pharmaceutical to become the actual controller

Shanghai Pharmaceuticals (601607) announced that Shanghai Hutchison Pharmaceuticals Co., Ltd. ("HUTCHMED") is a 50% joint venture between Shanghai Medicinal Materials Co., Ltd., a wholly-owned subsidiary of Shanghai Pharmaceutical, and Shanghai HUTCHMED Investments (Hong Kong) Limited ("HUTCHMED"). Shanghai Pharma intends to jointly acquire the equity interest in Shanghai Hutchison Pharmaceuticals held by HUTCHMED with the designated entity of Shanghai Gimpo Health Services Equity Investment Management Co., Ltd. Among them, Shanghai Pharmaceutical plans to acquire 10% of the equity for 995 million yuan. Upon completion of the transaction, Shanghai Pharma will hold a total of 60% equity interest in Shanghai Hutchison Pharmaceutical, which will be consolidated.

Shaanxi Guotou A: In 2025, it plans to use no more than 2.5 billion yuan to invest in the securities market

Shaanxi Guotou A (000563) announced that it plans to use no more than 2.5 billion yuan to invest in the securities market in 2025. The investment method is to use the company's securities proprietary account to carry out primary and secondary market investment in the capital market, build a stable investment portfolio, and the underlying assets include stocks, bonds, funds and other financial products authorized by the company to invest (excluding the company's trust plan), and strive to reduce portfolio risk through diversified allocation and obtain relatively stable returns.

Wantong Expressway: It is planned to acquire 100% of the shares of Fuzhou Company and Sixu Company for 4.771 billion yuan

Wantong Expressway (600012) announced that the company intends to acquire 100% of the shares of Anhui Fuzhou Expressway Co., Ltd. (hereinafter referred to as "Fuzhou Company") and 100% of the shares of Anhui Sixu Expressway Co., Ltd. (hereinafter referred to as "Sixu Company") held by the controlling shareholder Anhui Traffic Control Group for 4.771 billion yuan. After the completion of the transaction, the company's expressway main business will continue to expand through the acquisition, which will help improve the company's competitiveness in the regional road network. The total mileage of operating highways owned by the Company will increase significantly following the acquisition.

Huasu Holdings: The subsidiary plans to acquire 51% of the equity of Liulin Hangtai for 20.4 million yuan

Huasu Holdings (000509) announced that Hubei Carbon Space Technology Co., Ltd. (hereinafter referred to as "Carbon Space"), a wholly-owned subsidiary of the company, and Shanxi Aerospace Guotai Clean Energy Co., Ltd. (hereinafter referred to as "Aerospace Guotai") signed the "Equity Transfer Agreement" on December 27, 2024, and Carbon Space intends to acquire 51% of the equity of Liulin County Hangtai Clean Energy Co., Ltd. (hereinafter referred to as "Liulin Hangtai") held by Aerospace Guotai for 20.4 million yuan. After the completion of the transaction, Carbon Space will hold 51% of the equity of the target company and become the controlling shareholder of the target company, and the target company will become a holding subsidiary within the scope of the company's consolidated statements. This transaction can consolidate the foundation of the carbon emission management business of the company's wholly-owned subsidiary, build the hematopoietic capacity of the carbon cable space, and build the foundation of an integrated operation and service system of monitoring and governance supplemented by methane and other carbon emission gases.

Zhongheng Group: The products of the holding subsidiary are planned to be selected for centralized procurement by the National Proprietary Chinese Medicine Procurement Alliance

Zhongheng Group (600252) announced that according to the "Announcement of the Proposed Winning Results of the National Proprietary Chinese Medicine Procurement Alliance for Centralized Procurement with Volume" issued by the National Proprietary Chinese Medicine Joint Procurement Office on December 30, 2024 on the Hubei Medical Insurance Service Platform, the company's holding subsidiary Wuzhou Pharmaceutical Products Thrombotong (freeze-dried) for injection intends to win the bid for this centralized volume procurement.

Dabeinong: A number of products of its holding subsidiaries have been approved with GMO safety certificates

Dabeinong (002385) announced that on December 31, 2024, the Department of Science and Technology of the Ministry of Agriculture and Rural Affairs issued the 2024 agricultural genetically modified organism safety certificate approval list (3), and the insect-resistant and herbicide-resistant corn, soybean and other products developed by Beijing Dabeinong Biotechnology Co., Ltd., a holding subsidiary of the company, were approved.

Agricultural Development Seed Industry: The company's new corn and soybean varieties have passed the national examination

Agricultural Development Seed Industry (600313) announced that 6 new corn varieties and 1 new soybean variety independently cultivated by the company and some of its holding subsidiaries or jointly cultivated with others have been approved by the fifth meeting of the Fifth National Crop Variety Examination and Approval Committee.

Zhongke Cloud Network: Signed a letter of intent for cooperation in photovoltaic projects

Zhongke Cloud Network (002306) announced that on December 30, 2024, the company signed a "Letter of Intent for Cooperation" with Jiangsu Electric Power Design Institute to cooperate on the procurement of 1GW modules for the Yancheng photovoltaic project. This contract is a letter of intent for cooperation, and does not involve a specific amount for the time being.

Ganfeng Lithium: Providing project construction financing for the construction of solar photovoltaic power generation and energy storage power stations by the Malian government

Ganfeng Lithium (002460) announced that in order to promote the development of solar energy in the Republic of Mali (hereinafter referred to as "Mali"), the company signed the "Tripartite Agreement with the Malian Government and China Water Resources and Hydropower Construction Group Co., Ltd. - Financing for the Construction of Safo 50MWc Solar Photovoltaic Power Generation and 25MWh Energy Storage Power Station Phase I", and the company promised to build Safo 50MWc solar photovoltaic power generation and 25MWh energy storage power station Phase I project (hereinafter referred to as "Safo Power Station Project") for the Malian government ) to provide financing for the construction of the project up to $50 million. The Company or its holding subsidiaries will supply energy storage power station equipment to the Safo Power Station Project as part of this financing package.

Huasheng Co., Ltd.: The holding subsidiary plans to cooperate to build Lusong 1937 Cultural and Creative Industrial Park

Huasheng Co., Ltd. (600156) announced that in order to revitalize the company's land assets, enhance the company's land value, promote the company's business and products by building a cultural and creative industrial park, further expand brand influence and enhance the company's market competitiveness, the company's holding subsidiary Cedar Company cooperated with Binjiang Memory and Lusong Group to establish Lusong 1937 Cultural and Creative Industrial Park Co., Ltd. (hereinafter referred to as "Lusong 1937"), featuring cultural tourism and supporting business, to create an industrial cultural tourism gathering place. The registered capital of Lusong 1937 is 30 million yuan, and Cedar Company invests 14.7 million yuan, with a shareholding ratio of 49%.

Montnets Technology: Suspension of stock trading in the planning of issuing shares and paying cash to purchase assets

Montnets Technology (002123) announced that the company is planning to purchase assets by issuing shares and paying cash, and the target company of this transaction is Hangzhou Bicheng Digital Technology Co., Ltd. The company intends to purchase the control of the target company by issuing shares and paying cash, and raise matching funds, and this transaction will not lead to a change in the actual controller of the company. Trading in the company's shares has been suspended since the market opened on January 2.

Funeng Technology: Suspension of stock trading for the change of control

Funeng Technology (688567) announced that the company received a notice from the controlling shareholder Hong Kong Funeng and its concerted actor Ganzhou Innobank on December 31, and learned that Hong Kong Funeng and Ganzhou InnoTron intend to transfer part of the company's shares by agreement. If the above matters are finally reached, it will lead to a change in the controlling shareholder and actual controller of the company. The company's A-share shares have been suspended since the market opened on the morning of January 2, and the suspension time is expected to be no more than two trading days.

ST Huicheng: It plans to purchase 51% of the equity of Ruien Pharmaceutical for 47 million yuan, and the business will be expanded to the field of biomedicine

ST Huicheng (002168) announced that the company intends to purchase 51% of the shares of Chongqing Ruien Pharmaceutical Co., Ltd. (hereinafter referred to as "Ruien Pharmaceutical") for 47 million yuan in cash. After the completion of the acquisition, Ruien Pharma will become a holding subsidiary of the company and be included in the company's consolidated financial statements. Ruien Pharma is mainly a high-end generic drug MAH (Drug Marketing Authorization Holder) licensee enterprise with independent intellectual property rights for drug production, sales, product introduction, product research and development. After the completion of the transaction, the company's business will be expanded to the biomedical field, helping the company expand the second curve of operating performance growth and helping the company improve its overall asset quality.

Suihengyun A: Guangdong Shantou Chaonan Longtian 400MW and Chaoyang Heping 150MW fishery photovoltaic power generation projects were put into operation

Sui Hengyun A (000531) announced that on December 31, 2024, the Chaonan Longtian 400MW fishery-photovoltaic project invested and constructed by Shantou Hengpeng New Energy Co., Ltd., a holding subsidiary of the company, and the Chaoyang Heping 150MW fishery-photovoltaic complementary photovoltaic project invested and constructed by Shantou Guangyao New Energy Co., Ltd. were connected to the grid for power generation. The grid-connected power generation of the project will contribute to the company's green, low-carbon and high-quality development.

DEREN Electronics: The capital increase of its holding subsidiary Meta failed to arrive on time

DEREN Electronics (002055) disclosed the progress of the capital increase and share expansion of its holding subsidiary Meta. Up to now, Meta's capital increase has completed the GP application, and the follow-up ODI (overseas investment filing) and other related procedures have not been completed, and the capital increase has not been paid on time. During this period, the company repeatedly urged the investor Glento Meida to complete the preparation and confirmation of the corresponding work as soon as possible, and communicated in writing on the willingness to perform and the ability to perform, but did not receive a reply and confirmation from the investor. Meta will continue to enlist the support of some customers and suppliers, and actively promote the development of new financing channels and the design of settlement plans with creditors. The Company will maintain communication with Glento Meta on the follow-up resolution of Meta's capital increase, and will consider taking relevant measures to protect the Company's legitimate rights and interests if necessary.

Aisid: Glory has recently completed the share reform

Aisid (002416) disclosed that the company is the online and offline retail service provider of the Honor brand, and the authorized service provider of the Honor brand in Hong Kong, Thailand, Vietnam and other countries and regions. In 2020, the company and the team jointly invested 660 million yuan to participate in the joint acquisition of Honor. According to the information on Honor's official website, Honor Terminal Co., Ltd. has been changed to a joint stock limited company on December 28, 2024 in accordance with the law, and its company name has been changed to "Honor Terminal Co., Ltd." In addition, the company has not found any undisclosed material information that may or has had a significant impact on the trading price of the company's shares reported by the public media recently. The company, its controlling shareholders and actual controllers do not have any material matters that should be disclosed but have not been disclosed, or major matters that are in the planning stage.

[Performance].

BYD: In 2024, the sales volume of new energy vehicles will be 4.2721 million, a year-on-year increase of 41.26

BYD (002594) announced that the company's sales of new energy vehicles in December 2024 were 514,800, and the cumulative sales of new energy vehicles from January to December were 4,272,100, a year-on-year increase of 41.26%.

Cialis: In 2024, the sales of new energy vehicles will be 426,900, a year-on-year increase of 182.84

Cialis (601127) announced that the company's sales of new energy vehicles in December 2024 were 37,319, a year-on-year decrease of 9.57%; From January to December, 426885 new energy vehicles were sold, a year-on-year increase of 182.84%.

BAIC Blue Valley: The subsidiary's sales volume in 2024 will be 113,900 units, a year-on-year increase of 23.53

BAIC Blue Valley (600733) announced that its subsidiary Beijing New Energy Automobile Co., Ltd. sold 16,408 vehicles in December 2024 and 113,860 units from January to December, a year-on-year increase of 23.53%.

[Sign a big order].

Wasion Information: In December 2024, the winning contract amount is about 357 million yuan

Wasion Information (688100) announced that the total amount of the company's winning contracts in December 2024 was about 357 million yuan, accounting for 16.03% of the company's audited total operating income in 2023.

Fulongma: In 2024, the total contract amount of the winning bid for the sanitation service project is 4.607 billion yuan

Fulongma (603686) announced that the company will pre-win the bid for 5 sanitation service projects in December 2024, with a total first-year service fee of 12.4974 million yuan (accounting for 0.40% of the company's audited operating income in 2023); The total amount of the contract is 33.9034 million yuan. Up to now, the company has won 52 bids for environmental sanitation service projects in 2024, with a total annual amount of 768 million yuan in the first year and a total contract amount of 4.607 billion yuan, which will have a positive impact on the company's operating performance in 2025 and beyond.

[Do a repurchase].

Xueda Education: It is planned to repurchase the company's shares for 110 million yuan to 150 million yuan

Xueda Education (000526) announced that it intends to repurchase the company's shares for 110 million yuan to 150 million yuan, which will be used for equity incentive and/or cancellation, and the repurchase price will not exceed 66.8 yuan per share. In addition, the company has obtained a loan commitment letter issued by ICBC Xiamen Branch, agreeing to provide special loan support, with a loan amount of no more than 100 million yuan and a loan term of no more than 1 year.

The vast number of special materials: plans to repurchase the company's shares with 200 million to 400 million yuan

The majority of special materials (688186) announced that the company intends to repurchase shares with 200 million yuan to 400 million yuan, which will be used for equity incentives and/or employee stock ownership plans, and the repurchase price of shares will not exceed 26.22 yuan per share. The source of funds for the repurchase of shares is the special loan provided by the Zhangjiagang Branch of Huaxia Bank and the company's self-raised funds, of which the special loan does not exceed 240 million yuan.